Make an Appointment
-
Division of Medical Oncology181 Taylor Ave, Columbus, OH 43203 map
Dr. Cassandra Grenade is an oncologist in Columbus. She provides diagnostic and treatment services for patients suffering from all types of cancer.
Division of Medical Oncology
Accepting New Patients?
Yes, Dr. Cassandra N. Grenade is accepting new patients at this office.
Phone
Address
181 Taylor Ave, Columbus, OH 43203
Office Details
Insurance Accepted
- Medicare
Bio
Dr. Cassandra Grenade graduated from Ohio State University College Of Medicine in 2008.
Dr. Grenade has one office in Ohio where she specializes in Oncology and Hematology / Oncology.
Specialties
-
Oncology
As an oncologist, Dr. Grenade is trained to diagnose and treat all types and forms of cancer. Dr. Grenade may employ a variety of diagnostic tests such as biopsies, imaging tests, endoscopic tests and laboratory tests. She may offer treatment techniques such as chemotherapy or radiotherapy to combat the spread of cancer. Dr. Grenade may also provide emotional and palliative care, ensuring patients experience the highest quality of life possible.
-
Hematology / Oncology
As a hematologist / oncologist in Ohio, Dr. Grenade is capable of diagnosing and treating patients with blood-related disorders, malignancies, or cancers. Dr. Grenade may treat a range of conditions ranging from the the common to the very rare and complex. As a result, Dr. Grenade may provide care as part of a multidisciplinary team, working in conjunction with other specialists to ensure the highest possible standard of care.
Education & Training
Hospital Affiliations
- Arthur G James Cancer Hospital and Research Institute
- Ohio State University Hospitals
Languages Spoken
- English
Links & Social Media
Latest Oncology News
-
Catnip: The 'Why' Behind Cats' Favorite HighRobert Preidt, Dec 10, 2018 at 12:00 PM
-
Incontinence Drug May Cut Hot Flashes in Breast Cancer SurvivorsSteven Reinberg, HealthDay Reporter, Dec 7, 2018 at 9:00 AM
-
Healthy Lifestyle Lowers Odds of Breast Cancer's ReturnRobert Preidt, Dec 7, 2018 at 9:00 AM